MYM Appoints Howard Steinberg as Independent Director and Vice-Chairman of the Company

Wednesday, October 24, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

VANCOUVER, British Columbia, Oct. 24, 2018 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE:áMYM) (CSE: MYM.CN) (the

"Company" or "MYM") is pleased to announce the appointment of Howard Steinberg as independent Director and Vice-Chairman of the Company, effective October 24, 2018.

Mr.

Steinberg has more than 20 years investment experience as a senior executive, working within some of the largest financial institutions in the world. He has sat on over a dozen Boards including his current role as Executive Chairman of Parallax Developments Corp. He has invested personally and with global financial institutions in a wide range of industries in every area of the balance sheet. Mr. Steinberg has an MBA from the University of Western Ontario and is a CFA charterholder.

"It is with great excitement that I join the MYM team," said Howard Steinberg. "Bringing in leadership such as myself is a key step in the transformation process to realize our shared vision of becoming an industry leader. Together, I'm confident we can get there."

"It is an honour to welcome Howard to the MYM team," said Rob Gietl, CEO of MYM. "Howard brings with him a wealth of experience as a senior executive in a variety of businesses. His time spent in global finance and tenure as Executive Chairman of Parallax have put him in a prime position to help lead MYM to success with our projects around the world."

Mr. Steinberg was granted options to purchase 3,000,000 common shares of the Company in accordance with the Company's stock option plan for a period of four years. The options are exercisable at a price of $1.10 per share.á250,000 options will vest in a single tranche immediately. 250,000 options will vest every three months thereafter. Subject to Mr. Steinberg meeting certainátargets within the first 12 months of his appointment, the options will vestáimmediately. The expiry date of these options is October 24, 2022.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products.áMYM is a shareholder in two production projects in Quebec that are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in a cannabis production project in Australia. The "Northern Rivers Project" in New South Wales, Australia is expected to have 1.2 million square feet of cannabis production space. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.áMYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Rob Gietl, CEO MYM Nutraceuticals Inc.www.mym.ca

Keep up to date with MYM on our social media channels:

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Investor Relations

Brian Tasker+1-403-616-1045brian.tasker@mym.ca

Cision View original content:http://www.prnewswire.com/news-releases/mym-appoints-howard-steinberg-as-independent-director-and-vice-chairman-of-the-company-300736855.html

SOURCE MYM Nutraceuticals Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store